The agreement, announced by the White House, potentially unlocks a major new market for the mega-blockbuster drugs.

Biden’s Inflation Reduction Act, which passed in 2022, requires pharmaceutical companies to negotiate drug prices with ...

Dr. Mehmet Oz warned about the link between obesity and dementia during a Trump administration drug announcement just feet ...

Donald Trump has unveiled a deal to slash the price of GLP-1 weight loss drugs by two thirds. The White House’s deal with Novo Nordisk and Eli Lilly will see the prices of WeGovy and Ozempic, also ...

WASHINGTON (AP) — President Donald Trump unveiled a deal Thursday with drugmakers Eli Lilly and Novo Nordisk to expand ...

US President Donald Trump has announced deals that aim to lower the cost of popular weight-loss drugs, as pharmaceutical prices take centre stage in his administration's messaging around affordability ...

Medicare beneficiaries will soon be able to get obesity and Type 2 diabetes drugs for a $50 copay. But there are some ...

U.S. President Donald Trump on Thursday struck deals with obesity drug manufacturers Eli Lilly and Novo Nordisk aimed at ...

GLP-1s are about to get more affordable in the United States, thanks to a new deal announced Thursday, Nov. 6 by the Trump ...

The president’s agreement with drug companies involves a range of prices, depending on dose, product and how you’re paying.

President Trump announced a deal with Eli Lilly and Novo Nordisk to lower prices on hugely popular weight-loss drugs for Medicare, Medicaid and American patients who pay with their own money.

President Donald Trump has unveiled a deal with drugmakers Eli Lilly and Novo Nordisk to reduce prices for their obesity ...